Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

Published:2009-01 Issue:1 Volume:60 Page:219-224
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Akhmetshina Alfiya,Venalis Paulius,Dees Clara,Busch Nicole,Zwerina Jochen,Schett Georg,Distler Oliver,Distler Jörg H. W.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference15 articles.

1. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls;D'Angelo;Am J Med,1969

2. Mortality and causes of death in a Swedish series of systemic sclerosis patients;Hesselstrand;Ann Rheum Dis,1998

3. Systemic sclerosis: a prototypic multisystem fibrotic disorder;Varga;J Clin Invest,2007

4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

5. Novel treatment approaches to fibrosis in scleroderma;Distler;Rheum Dis Clin North Am,2008

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nailfold Capillary Changes in Adult Bangladeshi Patients with Systemic Lupus Erythematosus: Correlation with Disease Activity;European Journal of Medical and Health Sciences;2024-08-24

2. Perspective to precision medicine in scleroderma;Frontiers in Immunology;2024-01-18

3. Overview of Animal Models;Scleroderma;2024

4. The Role of Mesenchymal Stem Cells and Imatinib in the Process of Liver Fibrosis Healing Through CCL2-CCR2 and CX3CL1-CX3CR1 Axes;Reports of Biochemistry and Molecular Biology;2023-08-01

5. Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model;International Journal of Pharmaceutics;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3